Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07459582 · ClinicalTrials.gov registry record
Accuracy of Home Lactate Meter and Accu-chek Glucometer in Patients With Glycogen Storage Disease
A clinical trial of Glycogen Storage Disease Type Ia and Glycogen Storage Disease Type I, sponsored by Connecticut Children's Medical Center.
- Recruiting
- Registry status
- 10
- Enrollment target
- 1
- Study location
NCT07459582: Recruiting study of Glycogen Storage Disease Type Ia and Glycogen Storage Disease Type I, sponsored by Connecticut Children's Medical Center.
NCT07459582 is a study of Glycogen Storage Disease Type Ia and Glycogen Storage Disease Type I that is actively recruiting participants, run by Connecticut Children's Medical Center. The registered enrollment target is 10 participants, below the 49-participant average among 5 other Glycogen Storage Disease Type Ia trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07459582, a study of Glycogen Storage Disease Type Ia and Glycogen Storage Disease Type I, is actively recruiting participants, sponsored by Connecticut Children's Medical Center.
- RECRUITING
- Registry status
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to determine if the Lactate Plus meter is accurate compared to lab lactate levels, and to determine if the Accu chek guide glucometer is accurate compared to lab serum glucose levels in patients with Glycogen Storage Disease Types Ia, Ib and XI. To determine this, patient's will have a one-time planned admission to Connecticut Children's for approximately 8 hours and receive hourly blood draws as well as finger-sticks.
Conditions Studied
Interventions
- OTHER Lactate Meter
- DEVICE Accu Chek
Study Locations (1)
Connecticut
- Connecticut Children's - Hartford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2026-03 |
| Est. Completion | 2027-12 |
What NCT07459582 shows while recruiting
NCT07459582 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 49-participant average among 5 other Glycogen Storage Disease Type Ia trials with a reported enrollment target (80% lower).
The record links to 4 conditions, with Glycogen Storage Disease Type Ia appearing as the primary indexed condition, and to 2 interventions - of which Lactate Meter is the first listed.
NCT07459582 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT07459582 about?
NCT07459582 is a clinical study titled "Accuracy of Home Lactate Meter and Accu-chek Glucometer in Patients With Glycogen Storage Disease". The goal of this study is to determine if the Lactate Plus meter is accurate compared to lab lactate levels, and to determine if the Accu chek guide glucometer is accurate compared to lab serum glucose levels in patients with Glycogen Storage Disease Types Ia, Ib and XI. To determine this, patient'...
What is the current status of trial NCT07459582?
This trial is currently recruiting. The enrollment target is 10 participants. The study started on 2026-03. Estimated completion is 2027-12.
What conditions does trial NCT07459582 study?
This clinical trial studies the following conditions: Glycogen Storage Disease Type Ia, Glycogen Storage Disease Type I, Glycogen Storage Disease Type IB, Glycogen Storage Disease Xi.
What interventions are being tested in trial NCT07459582?
The interventions under investigation include: Lactate Meter (OTHER), Accu Chek (DEVICE).
Who is sponsoring clinical trial NCT07459582?
This trial is sponsored by Connecticut Children's Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07459582 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glycogen Storage Disease Type Ia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Accuracy of Lactate Meter in GSDIa
RECRUITING
-
A Phase 1/2, Dose-Exploration Study to Evaluate the Safety and Efficacy of BEAM-301 in Patients With Glycogen Storage Disease Type Ia (GSDIa)
RECRUITING · Phase 1
-
Glycogen Storage Disease Type Ia (GSDIa) Disease Monitoring Program
RECRUITING
-
A Study of Adeno-Associated Virus Serotype 8-Mediated Gene Transfer of Glucose-6-Phosphatase in Patients With Glycogen Storage Disease Type Ia (GSDIa)
COMPLETED · Phase 3
-
Study of Long-Term Safety and Efficacy on Gene Therapy in Glycogen Storage Disease Type Ia
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia